HIGHLIGHTS
- who: Yanyan Zhu from the Department of Oncology, Henan Provincial People`s Hospital, People`s Hospital of Zhengzhou University, School of Clinical Shenzhen, China have published the paper: BNIP3 Upregulation Characterizes Cancer Cell Subpopulation With Increased Fitness and Proliferation, in the Journal: (JOURNAL)
SUMMARY
The heterogeneity of cancer is a well-known phenomenon that poses a daunting challenge for effective treatment. Cell-to-cell variability in signaling pathways and transcription factor activities render the whole cancer cell population only partially responsive to most drugs. The design of a better combination targeting strategy relies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.